Angelo Navas

University of North Carolina at Chapel Hill

Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial”.

Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial

Trials(2021)10.1186/s13063-021-05341-2

N/A

0.419DataRank · unranked

10 citations

Laura V. Milko, Margaret Waltz, Ida Griesemer, Lonna Mollison, Tracey Grant +15 more

The Burden of COVID-19 on Caregivers of Children with Suspected Genetic Conditions: A Therapeutic Odyssey

Physical & Occupational Therapy In Pediatrics(2022)10.1080/01942638.2022.2138734

N/A

0DataRank · unranked

1 citations

Courtney Canter, Jeannette T. Bensen, Jonathan S. Berg, Ann Katherine M. Foreman, Tracey Grant +8 more

Facilitators and Barriers for Implementing Diagnostic Sequencing Technology for Pediatric Oncology in Low- and Middle-Income Countries

(2025)10.22541/au.175673365.53679045/v1

N/A

0DataRank · unranked

0 citations

Nathaniel J. Webb, Javeria Aijaz, Federico Antillón, Vaskar Saha, Rui Manuel Reis +12 more